Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Cancer - Statistics & Facts

Cancer is the second leading cause of death in the United States, making it one of modern medicine’s greatest challenges. The percentage of the U.S. population who has or ever had cancer has increased over the past 15 years. Furthermore, men have a higher chance of developing cancer than women. For 2020, it is estimated there will be around 1.8 million new cases of cancer and some 606,500 deaths attributable to cancer in the United States.

Breast and prostate cancers are the most prevalent forms of cancer amongst women and men respectively. From an ethnic point of view, African-American men are the group with the highest incidence rate of cancer in the United States. Kentucky and Delaware are the U.S. states where the rate of cancer is the highest, while New Mexico and Nevada have the lowest number of new cancer cases per 100,000 inhabitants.

While incidence rates are increasing, cancer death rates have constantly fallen since 1990. Men have a higher risk of mortality from cancer than women and African-Americans are the ethnic group with the highest number of cancer-related deaths per 100,000 population. Lung and bronchial cancer cause the highest number of cancer-related deaths. Approximately 63,220 women and 72,500 men are predicted to die from this type of cancer in 2020. The chance of surviving for a five-year period upon diagnosis of cancer has increased from 49 percent in the 1970s to 69 percent as of 2015.

The cancer drug market is among the top pharmaceutical therapeutic areas both in the United States, and worldwide. Expenditure on oncological medicine in the U.S. was worth some 58.4 billion U.S. dollars in 2018. The top cancer drug worldwide is Clegene's Revlimid, generating 8.19 billion U.S. dollars of revenue in 2018. The United States is a top global developer of new cancer drugs, with the largest groups aimed at treating solid tumors, lung cancer, and leukemia.

Key figures

The most important key figures provide you with a compact summary of the topic of "Cancer" and take you straight to the corresponding statistics.

Incidence & Death Rates

Probability of surviving

Risk factors

Cancer Drug Market

Interesting statistics

In the following 7 chapters, you will quickly find the {amountStatistics} most important statistics relating to "Cancer".

Cancer in the U.S.

Dossier on the topic

All important statistics are prepared by our experts – available for direct download as PPT & PDF!
TOP SELLER

Cancer - Statistics & Facts

Cancer is the second leading cause of death in the United States, making it one of modern medicine’s greatest challenges. The percentage of the U.S. population who has or ever had cancer has increased over the past 15 years. Furthermore, men have a higher chance of developing cancer than women. For 2020, it is estimated there will be around 1.8 million new cases of cancer and some 606,500 deaths attributable to cancer in the United States.

Breast and prostate cancers are the most prevalent forms of cancer amongst women and men respectively. From an ethnic point of view, African-American men are the group with the highest incidence rate of cancer in the United States. Kentucky and Delaware are the U.S. states where the rate of cancer is the highest, while New Mexico and Nevada have the lowest number of new cancer cases per 100,000 inhabitants.

While incidence rates are increasing, cancer death rates have constantly fallen since 1990. Men have a higher risk of mortality from cancer than women and African-Americans are the ethnic group with the highest number of cancer-related deaths per 100,000 population. Lung and bronchial cancer cause the highest number of cancer-related deaths. Approximately 63,220 women and 72,500 men are predicted to die from this type of cancer in 2020. The chance of surviving for a five-year period upon diagnosis of cancer has increased from 49 percent in the 1970s to 69 percent as of 2015.

The cancer drug market is among the top pharmaceutical therapeutic areas both in the United States, and worldwide. Expenditure on oncological medicine in the U.S. was worth some 58.4 billion U.S. dollars in 2018. The top cancer drug worldwide is Clegene's Revlimid, generating 8.19 billion U.S. dollars of revenue in 2018. The United States is a top global developer of new cancer drugs, with the largest groups aimed at treating solid tumors, lung cancer, and leukemia.

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Hadley Ward
Hadley Ward
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Ziyan Zhang
Ziyan Zhang
Customer Relations– Contact (Asia)

Mon - Fri, 11:30am - 10pm (IST)

Contact Kisara Mizuno
Kisara Mizuno
Customer Success Manager– Contact (Asia)

Mon - Fri, 9:30am - 5:30pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Catalina Rodriguez
Catalina Rodriguez
Key Account Manager - LAC– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)